Japan's generic drugmakers making efforts to stabilize supply, ensure quality

The Japan Generic Pharmaceutical Manufacturing Association has released the results of a survey which provides data on member companies' efforts to improve the reliability of their supply chains, the provision of information and ensuring quality control of generic drugs. The group said it carried out the study in response to the Japanese government's promotion of the use of generic drugs, which is targeting 30% coverage of the Japanese pharmaceutical market by copy drugs. This has led to concerns being expressed about stable supply, quality and the provision of generic drug information, by physicians, pharmacists and the general public.

The JGPMA conducted the survey for 40 member companies from October 1, 2007, through March 31, 2008, to grasp the achievement status of goals in the association's action plan.

Same or following-day delivery as standard